Lazard International Equity Advtg Instl IEAIX

Medalist Rating as of | See Lazard Investment Hub
  • NAV / 1-Day Return 13.09  /  +0.85 %
  • Total Assets 23.1 Mil
  • Adj. Expense Ratio
    0.800%
  • Expense Ratio 0.800%
  • Distribution Fee Level Average
  • Share Class Type Institutional
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 10,000
  • Status Open
  • TTM Yield 0.64%
  • Turnover 88%

USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:29 PM GMT+0

Morningstar’s Analysis IEAIX

Will IEAIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Lazard International Equity Advtg Instl’s management team is rated Average, but a solid investment process still helps this strategy retain its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IEAIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 20.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

3.42 723,852
Healthcare

ASML Holding NV

2.82 596,321
Technology

Japan Post Holdings Co Ltd

2.24 473,101
Financial Services

ABB Ltd

1.96 415,351
Industrials

GSK PLC

1.89 398,949
Healthcare

Taiwan Semiconductor Manufacturing Co Ltd

1.83 386,640
Technology

Constellation Software Inc

1.81 383,224
Technology

State Bank of India DR

1.64 347,743
Financial Services

Dr Reddy's Laboratories Ltd ADR

1.54 324,798
Healthcare

Dollarama Inc

1.45 307,698
Consumer Defensive

Sponsor Center